Back to 
CAPTRUST FINANCIAL ADVISORS
CAPTRUST FINANCIAL ADVISORS
SCNI1 quarters
Position history for CAPTRUST FINANCIAL ADVISORS's holdings in BIONDVAX PHARMACEUTICALS LTD
Yes. Captrust holds 12,035 shares of SCNI (Biondvax Pharmaceuticals), worth $3,040, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$3,040
Current Shares
12,035
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SCNI: UBS Group AG, CITADEL ADVISORS LLC